PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 77 filers reported holding PIERIS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $149,000 | +2.8% | 58,100 | 0.0% | 0.00% | – |
| Q4 2020 | $145,000 | +20.8% | 58,100 | 0.0% | 0.00% | – |
| Q3 2020 | $120,000 | -37.2% | 58,100 | -5.8% | 0.00% | – |
| Q2 2020 | $191,000 | +70.5% | 61,700 | +25.9% | 0.00% | – |
| Q1 2020 | $112,000 | -26.8% | 49,000 | +15.8% | 0.00% | – |
| Q4 2019 | $153,000 | +6.2% | 42,300 | 0.0% | 0.00% | – |
| Q3 2019 | $144,000 | -86.8% | 42,300 | -81.8% | 0.00% | -100.0% |
| Q2 2019 | $1,092,000 | +45.4% | 232,390 | +3.7% | 0.00% | – |
| Q1 2019 | $751,000 | +21.7% | 224,190 | -3.3% | 0.00% | – |
| Q4 2018 | $617,000 | -24.2% | 231,790 | +59.4% | 0.00% | -100.0% |
| Q3 2018 | $814,000 | +13.5% | 145,380 | +2.8% | 0.00% | – |
| Q2 2018 | $717,000 | -1.0% | 141,480 | +33.4% | 0.00% | -100.0% |
| Q1 2018 | $724,000 | +470.1% | 106,090 | +531.5% | 0.00% | – |
| Q4 2017 | $127,000 | +69.3% | 16,800 | +29.2% | 0.00% | – |
| Q3 2017 | $75,000 | +13.6% | 13,000 | 0.0% | 0.00% | – |
| Q2 2017 | $66,000 | – | 13,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 9,775,849 | $2,913,203 | 1.93% |
| Aquilo Capital Management, LLC | 3,303,190 | $984,351 | 0.89% |
| CM Management, LLC | 649,400 | $193,521 | 0.20% |
| BVF INC/IL | 20,609,863 | $6,141,739 | 0.17% |
| WEALTH EFFECTS LLC | 11,700 | $3,487 | 0.00% |
| NJ State Employees Deferred Compensation Plan | 30,000 | $8,940 | 0.00% |
| HUDSON VALLEY INVESTMENT ADVISORS INC /ADV | 14,000 | $4,172 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 962,358 | $286 | 0.00% |
| TWO SIGMA ADVISERS, LP | 24,400 | $7,271 | 0.00% |
| Tower View Wealth Management LLC | 1,000 | $0 | 0.00% |